Literature DB >> 21592959

Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.

Jason E Duex1, Laurey Comeau, Alexander Sorkin, Benjamin Purow, Benjamin Kefas.   

Abstract

Epidermal growth factor receptor (EGFR) is involved in development and progression of many human cancers. We have previously demonstrated that the ubiquitin-specific peptidase Usp18 (Ubp43) is a potent regulator of EGFR protein expression. Here we report that the 3'-untranslated region (3'-UTR) of the EGFR message modulates RNA translation following cell treatment with Usp18 siRNA, suggesting microRNA as a possible mediator. Given earlier evidence of EGFR regulation by the microRNA miR-7, we assessed whether miR-7 mediates Usp18 siRNA effects. We found that Usp18 depletion elevates miR-7 levels in several cancer cell lines because of a transcriptional activation and/or mRNA stabilization of miR-7 host genes and that miR-7 acts downstream of Usp18 to regulate EGFR mRNA translation via the 3'-UTR. Also, depletion of Usp18 led to a decrease in protein levels of other known oncogenic targets of miR-7, reduced cell proliferation and soft agar colony formation, and increased apoptosis. Notably, all of these phenotypes were reversed by a specific inhibitor of miR-7. Thus, our findings support a model in which Usp18 inhibition promotes up-regulation of miR-7, which in turn inhibits EGFR expression and the tumorigenic activity of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592959      PMCID: PMC3137108          DOI: 10.1074/jbc.M111.222760

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Active turnover modulates mature microRNA activity in Caenorhabditis elegans.

Authors:  Saibal Chatterjee; Helge Grosshans
Journal:  Nature       Date:  2009-09-06       Impact factor: 49.962

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

3.  UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Authors:  Qing Feng; David Sekula; Yongli Guo; Xi Liu; Candice C Black; Fabrizio Galimberti; Sumit J Shah; Lorenzo F Sempere; Vincent Memoli; Jesper B Andersen; Bret A Hassel; Konstantin Dragnev; Ethan Dmitrovsky
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

4.  Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7.

Authors:  Rebecca J Webster; Keith M Giles; Karina J Price; Priscilla M Zhang; John S Mattick; Peter J Leedman
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

5.  The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.

Authors:  Benjamin Kefas; Laurey Comeau; Desiree H Floyd; Oleksandr Seleverstov; Jakub Godlewski; Tom Schmittgen; Jinmai Jiang; Charles G diPierro; Yunqing Li; E Antonio Chiocca; Jeongwu Lee; Howard Fine; Roger Abounader; Sean Lawler; Benjamin Purow
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

Review 6.  Mechanisms of resistance to HER family targeting antibodies.

Authors:  Tim J Kruser; Deric L Wheeler
Journal:  Exp Cell Res       Date:  2010-01-11       Impact factor: 3.905

7.  Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosis.

Authors:  Harish Potu; Andrea Sgorbissa; Claudio Brancolini
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

8.  Expression, regulation and function of the ISGylation system in prostate cancer.

Authors:  A Kiessling; C Hogrefe; S Erb; C Bobach; S Fuessel; L Wessjohann; B Seliger
Journal:  Oncogene       Date:  2009-05-11       Impact factor: 9.867

9.  RNA interference screen identifies Usp18 as a regulator of epidermal growth factor receptor synthesis.

Authors:  Jason E Duex; Alexander Sorkin
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

10.  The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer.

Authors:  Nuran Bektas; Erik Noetzel; Jürgen Veeck; Michael F Press; Glen Kristiansen; Amjad Naami; Arndt Hartmann; Arno Dimmler; Matthias W Beckmann; Ruth Knüchel; Peter A Fasching; Edgar Dahl
Journal:  Breast Cancer Res       Date:  2008-07-15       Impact factor: 6.466

View more
  29 in total

1.  Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.

Authors:  Mio Kitano; Reza Rahbari; Erin E Patterson; Seth M Steinberg; Nijaguna B Prasad; Yongchun Wang; Martha A Zeiger; Electron Kebebew
Journal:  Thyroid       Date:  2012-02-03       Impact factor: 6.568

2.  Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition.

Authors:  Johan Tisserand; Konstantin Khetchoumian; Christelle Thibault; Doulaye Dembélé; Pierre Chambon; Régine Losson
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

Review 3.  The role of deubiquitinases in breast cancer.

Authors:  Zhenna Xiao; Peijing Zhang; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

4.  A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival.

Authors:  Benjamin Kefas; Desiree H Floyd; Laurey Comeau; Alyse Frisbee; Charli Dominguez; Charles G Dipierro; Fadila Guessous; Roger Abounader; Benjamin Purow
Journal:  Neuro Oncol       Date:  2013-10-24       Impact factor: 12.300

Review 5.  Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.

Authors:  Lisa Maria Mustachio; Yun Lu; Masanori Kawakami; Jason Roszik; Sarah J Freemantle; Xi Liu; Ethan Dmitrovsky
Journal:  Cancer Res       Date:  2018-01-17       Impact factor: 12.701

6.  Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner.

Authors:  Christine W Duarte; Christopher D Willey; Degui Zhi; Xiangqin Cui; Jacqueline J Harris; Laura Kelly Vaughan; Tapan Mehta; Raymond O McCubrey; Nikolai N Khodarev; Ralph R Weichselbaum; G Yancey Gillespie
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

Review 7.  Deubiquitinases in cancer.

Authors:  Rongbin Wei; Xiaodong Liu; Weixin Yu; Tianshu Yang; Wenping Cai; Junjun Liu; Xiao Huang; Guo-tong Xu; Shouliang Zhao; Jianhua Yang; Shangfeng Liu
Journal:  Oncotarget       Date:  2015-05-30

8.  USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2.

Authors:  Jamshed Warsi; Zohreh Hosseinzadeh; Bernat Elvira; Lisann Pelzl; Ekaterina Shumilina; Dong-Er Zhang; Karl S Lang; Philipp A Lang; Florian Lang
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

9.  Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7.

Authors:  Felicity C Kalinowski; Keith M Giles; Patrick A Candy; Alishum Ali; Clarissa Ganda; Michael R Epis; Rebecca J Webster; Peter J Leedman
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Systematic analysis of microRNA targeting impacted by small insertions and deletions in human genome.

Authors:  Anindya Bhattacharya; Jesse D Ziebarth; Yan Cui
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.